Your browser doesn't support javascript.
loading
The integration of systemic and tumor PD-L1 as a predictive biomarker of clinical outcomes in patients with advanced NSCLC treated with PD-(L)1blockade agents.
Zamora Atenza, Carlos; Anguera, Geòrgia; Riudavets Melià, Mariona; Alserawan De Lamo, Letícia; Sullivan, Ivana; Barba Joaquin, Andrés; Serra Lopez, Jorgina; Ortiz, M Angels; Mulet, Maria; Vidal, Sílvia; Majem, Margarita.
Afiliação
  • Zamora Atenza C; Group of Immunology-Inflammatory Diseases, Biomedical Research Institut Sant Pau (IIB Sant Pau), Barcelona, Spain.
  • Anguera G; Department of Medical Oncology, Hospital de La Santa Creu I San Pau. C, Sant Antoni Maria Claret 167 08025, Barcelona, Spain.
  • Riudavets Melià M; Department of Medicine, Universitat Autónoma de Barcelona (UAB), Barcelona, Spain.
  • Alserawan De Lamo L; Department of Medical Oncology, Hospital de La Santa Creu I San Pau. C, Sant Antoni Maria Claret 167 08025, Barcelona, Spain.
  • Sullivan I; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
  • Barba Joaquin A; Department of Immunology, Hospital de La Santa Creu I Sant Pau, Barcelona, Spain.
  • Serra Lopez J; Department of Medical Oncology, Hospital de La Santa Creu I San Pau. C, Sant Antoni Maria Claret 167 08025, Barcelona, Spain.
  • Ortiz MA; Department of Medical Oncology, Hospital de La Santa Creu I San Pau. C, Sant Antoni Maria Claret 167 08025, Barcelona, Spain.
  • Mulet M; Department of Medical Oncology, Hospital de La Santa Creu I San Pau. C, Sant Antoni Maria Claret 167 08025, Barcelona, Spain.
  • Vidal S; Group of Immunology-Inflammatory Diseases, Biomedical Research Institut Sant Pau (IIB Sant Pau), Barcelona, Spain.
  • Majem M; Group of Immunology-Inflammatory Diseases, Biomedical Research Institut Sant Pau (IIB Sant Pau), Barcelona, Spain.
Cancer Immunol Immunother ; 71(8): 1823-1835, 2022 Aug.
Article em En | MEDLINE | ID: mdl-34984538

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Immunol Immunother Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Immunol Immunother Ano de publicação: 2022 Tipo de documento: Article